Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 8/2020

01-08-2020 | Suicide | Letter to the Editor

Letter to the Editor in Response to: Clayville K, Miller P. Sulmasy, et al.: Physician-Assisted Suicide: Against Medical Neutrality

Author: William B. Ventres, MD, MA

Published in: Journal of General Internal Medicine | Issue 8/2020

Login to get access

Excerpt

I read with interest the letters [1, 2] regarding Sulmasy et al.’s 2018 JGIM article, “Physician-Assisted Suicide: Why Neutrality by Organized Medicine Is Neither Neutral nor Appropriate.” [3] I found them fascinating, as they reminded me of my 15 years practicing as a community-based physician in Oregon. There medical aid in dying (MAID)/physician-assisted suicide (PAS), depending on one’s particular viewpoint, has been hotly debated before and since becoming a legally authorized medical intervention in 1997 [4]. …
Literature
1.
Clayville K, Miller P. Sulmasy et al.: Physician-assisted suicide: against medical neutrality. J Gen Intern Med. 2019;34:1371.CrossRef
2.
Sulmasy DP, Finlay I, Fitzgerald F, et al. Physician-assisted suicide: against medical neutrality. J Gen Intern Med. 2019;34:1372.CrossRef
3.
Sulmasy DP, Finlay I, Fitzgerald F., et al. Physician-assisted suicide: why neutrality by organized medicine is neither neutral nor appropriate. J Gen Intern Med. 2018;33:1394–1399.CrossRef
4.
5.
Ventres W, Haq C. Toward a cultural consciousness of self-in-relationship: from “us and them” to “we”. Fam Med. 2014;46:691–695.PubMed
Metadata
Title
Letter to the Editor in Response to: Clayville K, Miller P. Sulmasy, et al.: Physician-Assisted Suicide: Against Medical Neutrality
Author
William B. Ventres, MD, MA
Publication date
01-08-2020
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 8/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05591-6

Other articles of this Issue 8/2020

Journal of General Internal Medicine 8/2020 Go to the issue

Viewpoint

Health Disparities and the Coronavirus Disease 2019 (COVID-19) Pandemic in the USA

Concise Research Report

Online Crowdfunding Response to Coronavirus Disease 2019

Original Research

Americans’ COVID-19 Stress, Coping, and Adherence to CDC Guidelines

Original Research

Baseline Factors Associated with Mortality in Patients Who Engaged in Buprenorphine Treatment for Opioid Use Disorder: a Cohort Study

Viewpoint

The Beast, the Borg, and the Role of the EMR

Original Research

A Prospective Study of Physical Activity, Sedentary Behavior, and Incidence and Progression of Lower Urinary Tract Symptoms
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits